New Findings Show (HRT) Almost Doubles Breast Cancer Death Risk

.

Breast Cancer

Women’s Health Initiative recently released new findings suggesting that Prempro hormone replacement therapy almost doubles the death risk from breast cancer.

A study conducted by the LA Biomedical Research Institute (LABRI) at harbor-UCLA Medical Center in 2002 found that the combination of estrogen and progesterone led to an increase in cases of breast cancer, making hormone replacement therapy generally a dangerous option for postmenopausal women. The study revealed that Prempro hormones, which were once used by millions of women, were in fact linked to higher rates of breast cancer and heart disease.

The initial findings in 2002 led to a decline in hormone use, with about 100,000 fewer invasive tumors detected from 2002-2007 than expected. The study continued to track 12,788 women for almost 8 years after the trials were stopped and found that for every 10,000 women, there were 2.6 deaths in those taking hormones and only 1.3 in those on a placebo.

These more recent findings conflict with previous studies showing that women with breast cancer who were taking hormones had a lower risk of death.

Peter Bach of Memorial Sloan-Kettering Cancer Center’s health outcomes research group said: “Given the substantial population of women who seek relief from menopausal symptoms and the large potential burden of disease that could be created if medications given to alleviate symptoms today cause cancer and other deaths tomorrow, it seems that additional randomized trials are needed”.


Latest News

Wal-Mart’s Total Sales Drop; The Retailer will Introduce its ‘Door-Greeter’ Prog
Two Fire Incidents in Federal Center SW Station Leads to a Shut Down
Increasing Number of Car Makers Collaborating with Tech Companies to Develop Sel
Mortgage Rates Move Back Close to Its Yearly Low
Fire threatens entire city in Alberta
George Bush to stay out of the presidential campaign
Teen Retailer Aeropostale Files for Bankruptcy Protection; Closing Twenty Percen
Zynga’s Q1 Earnings Repot Beats Analysts’ Estimates
Tribune Publishing Says ‘No’ to Gannett Company’s Takeover Offer
Tesla Motors Posts Loss in the First Quarter that’s Larger than Last Year